This interactive symposium will feature expert perspectives on advancing the standard of care for individuals living with PBC. Discussion will focus on strategies aimed at achieving normalization of biochemical markers, alleviating symptom burden, and exploring the potential role of new and emerging therapies in improving patient outcomes.
Supported by: Gilead Sciences, Inc.
Organized by: Clinical Care Options, LLC